We have recently demonstrated that YY1 is involved in CXCR4 and VEGF pathways [19,20] which have both been genetically amplified and correlated with poor survival of soft-tissue sarcomas [8,31,32]. This evidence concerns the gene CXCR4 and soft tissue sarcoma.